CPSC FDA Critical Low Moderate Clear all

All Recalls

Back to home ←

FDA•Jan 2, 2026MODERATE
Lanreotide Injection 120 mg/0.5 mL
Cipla is recalling Lanreotide Injection 120 mg/0.5 mL (NDC 69097-870-67) due to particulate matter contamination.